Entrada Therapeutics is a clinical-stage biopharmaceutical company focused on developing a new class of medicines for intracellular targets. The company is advancing a portfolio of genetic medicines for neuromuscular and inherited retinal diseases. Entrada has multiple clinical data readouts expected by 2026 for its Duchenne muscular dystrophy (DMD) programs and is collaborating with Vertex Pharmaceuticals on a program for myotonic dystrophy type 1 (DM1). Entrada is seeking colleagues who are ready to join a high-energy, dedicated team focused on improving patient lives.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Associate degree